Clinical Trials Directory

Trials / Active Not Recruiting

Active Not RecruitingNCT05916378

Achieving Equity in Genomic Testing for Breast Cancer Through Partner-Led Strategies and Policies

Status
Active Not Recruiting
Phase
Study type
Observational
Enrollment
150 (estimated)
Sponsor
Stanford University · Academic / Other
Sex
All
Age
18 Years – 99 Years
Healthy volunteers
Not accepted

Summary

The purpose of this study is to identify the barriers, and the extent of said barriers, to genomic testing for breast cancer patients among low-income and minority populations, particularly throughout Northern California. The investigators have created a survey that is available online for any patient with cancer to fill out voluntarily regarding their experiences to date. The survey is available at: https://stanforduniversity.qualtrics.com/jfe/form/SV\_7VElf8oesWcB3bE

Detailed description

The study has two main data-collecting phases. In phase 1, the investigators will engage multilevel stakeholders to respond to a survey assessing experience with and perceptions of genomic testing and its accessibility for patients with breast cancer in California. In phase 2, selected and interested survey participants who voluntarily provide their contact information on the survey will be asked to participate in an in-depth 1:1 semi-structured interview to explore disparities in genomic testing for breast cancer more closely. The investigators will then utilize their findings from both phases to present aggregate findings to an Expert Panel and Community Advisory Board and work together to develop policy recommendations. The policy recommendations will then be presented to policy makers, with the aim of identifying sustainable solutions that address breast cancer treatment and outcome disparities throughout Northern California.

Conditions

Timeline

Start date
2023-05-22
Primary completion
2024-10-31
Completion
2025-03-30
First posted
2023-06-23
Last updated
2024-11-22

Locations

1 site across 1 country: United States

Source: ClinicalTrials.gov record NCT05916378. Inclusion in this directory is not an endorsement.